[1]
|
Hart, W.R. (2005) Diagnostic Challenge of Secondary (Metastatic) Ovarian Tumors Simulating Primary Endometrioid and Mucinous Neoplasms. Pathology International, 55, 231-243. https://doi.org/10.1111/j.1440-1827.2005.01819.x
|
[2]
|
Bruls, J., Simons, M., Overbeek, L.I., et al. (2015) A Na-tional Population-Based Study Provides Insight in the Origin of Malignancies Metastatic to the Ovary. Virchows Archiv: An International Journal of Pathology, 467, 79-86.
https://doi.org/10.1007/s00428-015-1771-2
|
[3]
|
Irving, J.A. and Young, R.H. (2005) Lung Carcinoma Metastatic to the Ovary: A Clinicopathologic Study of 32 Cases Emphasizing Their Morphologic Spectrum and Problems in Dif-ferential Diagnosis. The American Journal of Surgical Pathology, 29, 997-1006. https://doi.org/10.1097/01.pas.0000166363.76082.a0
|
[4]
|
Giordano, G., Viruel, N.C., Silini, E.M. and Nogales, F.F. (2017) Adenocarcinoma of the Lung Metastatic to the Ovary With a Signet Ring Cell Component. International Journal of Surgical Pathology, 25, 365-367.
https://doi.org/10.1177/1066896917691613
|
[5]
|
Karaosmanoglu, A.D., Onur, M.R., Salman, M.C., et al. (2019) Imaging in Secondary Tumors of the Ovary. Abdominal Radiology, 44,1493-1505. https://doi.org/10.1007/s00261-018-1809-4
|
[6]
|
Koyama, T., Mikami, Y., Saga, T., et al. (2007) Secondary Ovar-ian Tumors: Spectrum of CT and MR Features with Pathologic Correlation. Abdominal Imaging, 32, 784-795. https://doi.org/10.1007/s00261-007-9186-4
|
[7]
|
Suzuki, A., Shijubo, N., Yamada, G., et al. (2005) NapsinA Is Useful to Distinguish Primary Lung Adenocarcinoma from Adenocarcinomas of Other Organs. Pathology—Research and Practice, 201, 579-586.
https://doi.org/10.1016/j.prp.2005.05.010
|
[8]
|
Bishop, J.A., Sharma, R. and Illei, P.B. (2009) Napsin A and Thy-roid Transcription Factor-1 Expression in Carcinomas of the Lung, Breast, Pancreas, Colon, Kidney, Thyroid, and Ma-lignant Mesothelioma. Human Pathology, 41, 20-25.
https://doi.org/10.1016/j.humpath.2009.06.014
|
[9]
|
Stenhouse, G., Fyfe, N., King, G., Chapman, A. and Kerr, K.M. (2004) Thyroid Transcription Factor 1 in Pulmonary Adenocarcinoma. Journal of Clinical Pathology, 57, 383-387. https://doi.org/10.1136/jcp.2003.007138
|
[10]
|
Ng, W.K., Chow, J.C.Y. and Ng, P.K.H. (2002) Thyroid Transcrip-tion Factor-1 Is Highly Sensitive and Specific in Differentiating Metastatic Pulmonary from Extrapulmonary Adenocar-cinoma in Effusion Fluid Cytology Specimens. Cancer Cytopathology, 96, 43-48. https://doi.org/10.1002/cncr.10310
|
[11]
|
Fujiwara, S., Nawa, A., Nakanishi, T., et al. (2009) Thyroid Transcription Factor 1 Expression in Ovarian Carcinomas is an Independent Prognostic Factor. Human Pathology, 41, 560-565. https://doi.org/10.1016/j.humpath.2009.09.010
|
[12]
|
Bi, R., Bai, Q., Zhu, X., et al. (2019) ALK Rearrangement: A High-Frequency Alteration in Ovarian Metastasis from Lung Adenocarcinoma. Diagnostic Pathology, 14, Article No. 96. https://doi.org/10.1186/s13000-019-0864-7
|
[13]
|
Yao, S., Wang, L., Tian, X., et al. (2021) Lung Adenocarcinoma with Metachronous Ovarian Metastasis: A Long Survival Case Report. BMC Women’s Health, 21, Article No. 152. https://doi.org/10.1186/s12905-021-01284-7
|